Status:
UNKNOWN
Interest in Probabilistic Antibiotic Therapy With Broad-spectrum Beta-lactams in Orthopedic Surgery
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Joint Infection
Eligibility:
All Genders
18+ years
Brief Summary
The management of Joint Infections (JIs) requires a medical-surgical team which includes rheumatologists, infectious disease specialists, orthopedists as well as microbiologists. This collaboration m...
Eligibility Criteria
Inclusion
- Adult patient (≥18 years old)
- Hospitalized in the ortho-traumatology department
- Operated between January 1, 2021 and December 31, 2021
- Probabilistic antibiotic therapy with cefepime or piperacillin-tazobactam combined with an anti-gram + antibiotic
- Operated for: Change or washing of THA, TKA, PTE, ablation or resumption of osteosynthesis lower limbs and upper limbs and native osteitis
- Absence of written opposition in the medical file of the subject (and/or their legal representative if applicable) to the reuse of their data for scientific research purposes. It is the responsibility of the investigator to verify the absence of opposition in the patient's medical file.
Exclusion
- Patient having expressed his opposition to the reuse of his data for scientific research purposes.
- Minor patient
- Patient operated for: Amputation, plantar perforating pain, soft tissue infection
- Patient for whom there is documentation leading to targeted probabilistic antibiotic therapy with beta lactams.
Key Trial Info
Start Date :
July 17 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06191601
Start Date
July 17 2023
End Date
July 1 2024
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Orthopédie - Traumatologie Membre Supérieur - CHU de Strasbourg - France
Strasbourg, France, 67091